Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1977 2
1978 1
1979 5
1980 1
1981 2
1982 1
1983 6
1984 5
1985 2
1986 10
1987 12
1988 9
1989 8
1990 8
1991 9
1992 19
1993 17
1994 11
1995 10
1996 13
1997 19
1998 13
1999 20
2000 23
2001 31
2002 39
2003 21
2004 31
2005 28
2006 40
2007 44
2008 45
2009 58
2010 67
2011 70
2012 69
2013 89
2014 104
2015 104
2016 114
2017 120
2018 96
2019 115
2020 141
2021 112
Text availability
Article attribute
Article type
Publication date

Search Results

1,578 results
Results by year
Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results. The following terms were ignored: %, %, %, % The following terms were not found in PubMed: 22Bruck, 5BAuthor
Page 1
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D UI) …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI …
'Worse than death' and waiting for a joint arthroplasty.
Scott CEH, MacDonald DJ, Howie CR. Scott CEH, et al. Bone Joint J. 2019 Aug;101-B(8):941-950. doi: 10.1302/0301-620X.101B8.BJJ-2019-0116.R1. Bone Joint J. 2019. PMID: 31362549 Free PMC article. Clinical Trial.

AIMS: The EuroQol five-dimension (EQ-5D) questionnaire is a widely used multiattribute general health questionnaire where an EQ-5D < 0 defines a state 'worse than death' (WTD). ...Multivariate logistic regression was performed. EQ-5D and OHS/OKS were repea

AIMS: The EuroQol five-dimension (EQ-5D) questionnaire is a widely used multiattribute general health questionnaire where an EQ-5D
Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.
Lara B, Carnes A, Dakterzada F, Benitez I, Piñol-Ripoll G. Lara B, et al. Eur J Neurol. 2020 Sep;27(9):1744-1747. doi: 10.1111/ene.14339. Epub 2020 Jun 24. Eur J Neurol. 2020. PMID: 32449791 Free PMC article.
All patients had undergone a previous evaluation during the month before the lockdown, and were re-evaluated after 5 weeks of lockdown. The Neuropsychiatric Inventory (NPI) and EuroQol-5D questionnaire (EQ-5D) were used to assess neuropsychiatric symptoms in patient …
All patients had undergone a previous evaluation during the month before the lockdown, and were re-evaluated after 5 weeks of lockdown. The …
A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.
Brigandi RA, Johnson B, Oei C, Westerman M, Olbina G, de Zoysa J, Roger SD, Sahay M, Cross N, McMahon L, Guptha V, Smolyarchuk EA, Singh N, Russ SF, Kumar S; PHI112844 Investigators. Brigandi RA, et al. Am J Kidney Dis. 2016 Jun;67(6):861-71. doi: 10.1053/j.ajkd.2015.11.021. Epub 2016 Jan 27. Am J Kidney Dis. 2016. PMID: 26827289 Free article. Clinical Trial.
SETTING & PARTICIPANTS: Anemic non-dialysis-dependent patients with CKD stages 3-5 (CKD-3/4/5 group; n=70) and anemic hemodialysis patients with CKD stage 5D (CKD-5D group; n=37). INTERVENTIONS: Patients with CKD-3/4/5 received placebo or GSK1278863 (10, 25, 50, …
SETTING & PARTICIPANTS: Anemic non-dialysis-dependent patients with CKD stages 3-5 (CKD-3/4/5 group; n=70) and anemic hemodialysis patie …
Complications and outcome after rib fracture fixation: A systematic review.
Peek J, Beks RB, Hietbrink F, Heng M, De Jong MB, Beeres FJP, Leenen LPH, Groenwold RHH, Houwert RM. Peek J, et al. J Trauma Acute Care Surg. 2020 Aug;89(2):411-418. doi: 10.1097/TA.0000000000002716. J Trauma Acute Care Surg. 2020. PMID: 32282759
The most frequently used questionnaire to assess patient quality of life was the EuroQol-5D (EQ-5D) (n = 4). Four studies reporting on the EQ-5D had a weighted mean EQ-5D index of 0.80 indicating good quality of life after rib fracture fixation. ...
The most frequently used questionnaire to assess patient quality of life was the EuroQol-5D (EQ-5D) (n = 4). Four studies repo …
Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057.
Reck M, Brahmer J, Bennett B, Taylor F, Penrod JR, DeRosa M, Dastani H, Spigel DR, Gralla RJ. Reck M, et al. Eur J Cancer. 2018 Oct;102:23-30. doi: 10.1016/j.ejca.2018.05.005. Epub 2018 Aug 10. Eur J Cancer. 2018. PMID: 30103096 Clinical Trial.
LCSS 3-item global index (3-IGI), EQ-5D utility index and EQ-5D visual analogue scale (VAS) scores were also determined. ...HRQoL improvements with nivolumab versus docetaxel were also supported by the LCSS 3-IGI, EQ-5D VAS and MMRM analysis. Time to first HR …
LCSS 3-item global index (3-IGI), EQ-5D utility index and EQ-5D visual analogue scale (VAS) scores were also determined. ...HR …
EQ-5D: a plea for accurate nomenclature.
Brooks R, Boye KS, Slaap B. Brooks R, et al. J Patient Rep Outcomes. 2020 Jul 3;4(1):52. doi: 10.1186/s41687-020-00222-9. J Patient Rep Outcomes. 2020. PMID: 32620995 Free PMC article.
Since 2009, EQ-5D has been available in three versions: EQ-5D-3L, EQ-5D-5L, and EQ-5D-Y, where 3L stands for three levels, 5L for five levels, and Y for youth. ...Two surveys - of arthritis applications, and 82 recent publications - found a variety of …
Since 2009, EQ-5D has been available in three versions: EQ-5D-3L, EQ-5D-5L, and EQ-5D-Y, where 3L stands for thr …
Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man.
Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG, Thorner MO. Ho KY, et al. J Clin Invest. 1988 Apr;81(4):968-75. doi: 10.1172/JCI113450. J Clin Invest. 1988. PMID: 3127426 Free PMC article.
Concomitantly, fasting resulted in a decline (day 1 vs. day 5) in serum concentrations of somatomedin C (1.31 +/- 0.22 vs. 0.77 +/- 0.18 U/ml) and glucose (4.9 +/- 0.2 vs. 3.2 +/- 0.2 mmol/liter), and a marked rise in free fatty acid (0.43 +/- 0.12 vs. 1.55 +/- 0.35 mmol/l …
Concomitantly, fasting resulted in a decline (day 1 vs. day 5) in serum concentrations of somatomedin C (1.31 +/- 0.22 vs. 0.77 +/- 0 …
Effect of patient education and physical training on quality of life and physical exercise capacity in patients with paroxysmal or persistent atrial fibrillation: A randomized study.
Joensen AM, Dinesen PT, Svendsen LT, Hoejbjerg TK, Fjerbaek A, Andreasen J, Sottrup MB, Lundbye-Christensen S, Vadmann H, Riahi S. Joensen AM, et al. J Rehabil Med. 2019 Jun 18;51(6):442-450. doi: 10.2340/16501977-2551. J Rehabil Med. 2019. PMID: 30931484 Free article. Clinical Trial.
At baseline, after 3, 6 and 12 months participants completed 5 different quality of life questionnaires (Quality of Life in patients with Atrial Fibrillation (AF-QoL-18), Atrial Fibrillation Effect on QualiTy of Life (AFEQT), Patient Health Questionnaire (PHQ-9), Generalised Anxi …
At baseline, after 3, 6 and 12 months participants completed 5 different quality of life questionnaires (Quality of Life in patients with At …
Validity and reliability of EQ-5D-5L among patients with axial spondyloarthritis in Singapore.
Seng JJB, Kwan YH, Fong W, Phang JK, Lui NL, Thumboo J, Leung YY. Seng JJB, et al. Eur J Rheumatol. 2020 Apr;7(2):71-78. doi: 10.5152/eurjrheum.2020.19043. Epub 2020 Apr 1. Eur J Rheumatol. 2020. PMID: 32644927 Free PMC article.
The test-retest reliability of the EQ-5D-5L was good with a weighted kappa of 0.61 for mobility, self-care, usual activities, and anxiety/depression; the ICC was 0.92 and 0.99 for the EQ-5D-5L index and visual analog scale (VAS) scores, respectively. The weighted ka …
The test-retest reliability of the EQ-5D-5L was good with a weighted kappa of 0.61 for mobility, self-care, usual activities, and anx …
1,578 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page